Unexpected Prevalence of Rare High-Risk HPV Types Demonstrates Utility of Zeesan Biotech Assay in Low-Resource Setting
May 29, 2019 | Madeleine Johnson
NEW YORK (GenomeWeb) – An evaluation of an HPV typing assay from Zeesan Biotech has shown the firm’s test kit can be incorporated successfully into an inexpensive screening protocol and run near patients in a low-resource setting. (More reading)
Related article published on Journal of Global Oncology can be found here.